Risk-Based Monitoring for All

Register for this webinar to learn about how ICH E6(R2) has given clinical development organizations the perfect opportunity to improve quality and lower costs through adoption of RBM and Centralized Monitoring.

Register

Implementing Risk-Based Monitoring - What Does ICH E6 Rev2 Mean for Me and My Company?

For this webinar, CluePoints teamed up with Paragon Solutions, to share everything organizations need to know about the ICH E6 Rev2.

Watch the Recording

Secrets of Successful Risk-Based Monitoring Revealed

For this webinar, CluePoints teamed up with Paragon Solutions, to share details on what organizations require to plan, document, implement, and evolve a bullet-proof Risk-Based Monitoring strategy.

Watch the Recording

Removing the Risk in Risk-Based Monitoring

What We’ve learnt in the Past Four Years from the Practical Implementation of RBM

This recording details best practices for on-boarding RBM that have been gained through implementation involving smaller and larger BioPharma sponsors and CROs.

Watch the Recording

The Complete Integrated Risk-Based Monitoring Solution

Harnessing the Power of Multiple Technology Systems to Drive RBM and Overall Data Quality Oversight

Watch the recording hosted by CluePoints and Oracle Health Sciences, to learn from two market leaders about an optimal way to get actionable results from the comprehensive analysis of clinical and operational data.

Watch the Recording

De-Risking it All - A Systematic and Proven Approach to RBM and Data Quality Oversight

Watch this recording to learn about how a unique combination of data analytics and Electronic Data Capture is being harnessed by large, medium and smaller pharma to de-risk clinical studies and drive RBM.

Watch the Recording

Risk-Based Monitoring - What We've Learned in a Year, a Large Pharma Perspective from Sanofi

Watch this recording to learn about how Sanofi-Aventis harnessed Central Statistical monitoring techniques to improve data quality and oversight. This session showcases the impact that Sanofi has had on enhancing its technology-driven approach.

Watch the Recording 

Risk-Based Monitoring and Central Statistical Monitoring

A Regulatory Perspective on What is Expected from an Independent and objective Assessment of Clinical Data

This webinar recording provides a regulatory perspective on what is expected from an independent and objective assessment of clinical data. Discussion points include what the FDA and EMA are encouraging sponsors to look at as part of their assessment of data quality, the types of data analysis required to de-risk studies and more.

Watch the Recording

Risk-Based Monitoring Improves Data Quality - It's a Fact!

In this webinar recording, Cubist Pharmaceuticals and CluePoints explore how sponsors are harnessing the power of Central Statistical Monitoring (CSM) to improve data quality and de-risk their studies. Discussion points include Risk-Based Monitoring, how to harness Central Statistical Monitoring in trials and more.

Watch the Recording

Removing the Risk in Risk-Based Monitoring - A Practical and Proven Approach to Implementing Central Statistical Monitoring

This webinar recording provides an in-depth examination of Central Statistical Monitoring (CSM) with an emphasis on statistical principles underlying Central Statistical Monitoring, On-Site Monitoring V.S CSM and more.

Watch the Recording